Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entinostat Combined With Chemotherapy as Second-line Therapy for Bladder Cancer
NCT07261592Phase 2Not yet recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Dec 2025
- Primary completion
- Sep 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of entinostat in bladder cancer, sponsored by Nanjing Drum-Tower Hospital. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
entinostat
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT07261592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07261592.